378 related articles for article (PubMed ID: 31441464)
1. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy.
Xue T; Xu C; Wang Y; Wang Y; Tian H; Zhang Y
Biomater Sci; 2019 Nov; 7(11):4615-4623. PubMed ID: 31441464
[TBL] [Abstract][Full Text] [Related]
2. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
3. Dual Roles of Metal-Organic Frameworks as Nanocarriers for miRNA Delivery and Adjuvants for Chemodynamic Therapy.
Zhao H; Li T; Yao C; Gu Z; Liu C; Li J; Yang D
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6034-6042. PubMed ID: 33499584
[TBL] [Abstract][Full Text] [Related]
4. Ultra-thin metal-organic framework nanosheets for chemo-photodynamic synergistic therapy.
Zeng R; He T; Lu L; Li K; Luo Z; Cai K
J Mater Chem B; 2021 May; 9(20):4143-4153. PubMed ID: 33973611
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors.
Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410
[TBL] [Abstract][Full Text] [Related]
6. Phosphate-Degradable Nanoparticles Based on Metal-Organic Frameworks for Chemo-Starvation-Chemodynamic Synergistic Antitumor Therapy.
Peng H; Qin YT; Feng YS; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37713-37723. PubMed ID: 34340302
[TBL] [Abstract][Full Text] [Related]
7. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors.
Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582
[TBL] [Abstract][Full Text] [Related]
8. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
9. Metal-Organic Sheets for Efficient Drug Delivery and Bioimaging.
Song Y; Yang J; Wang L; Xie Z
ChemMedChem; 2020 Mar; 15(5):416-419. PubMed ID: 31919981
[TBL] [Abstract][Full Text] [Related]
10. PVA reinforced gossypolone and doxorubicin π-π stacking nanoparticles towards tumor targeting and ultralow dose synergistic chemotherapy.
Liu Y; Li K; Wu Y; Ma J; Tang P; Liu Y; Wu D
Biomater Sci; 2019 Aug; 7(9):3662-3674. PubMed ID: 31179466
[TBL] [Abstract][Full Text] [Related]
11. Engineering Metal-Organic Frameworks for Photoacoustic Imaging-Guided Chemo-/Photothermal Combinational Tumor Therapy.
Zhang Y; Wang L; Liu L; Lin L; Liu F; Xie Z; Tian H; Chen X
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41035-41045. PubMed ID: 30403471
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the Antitumor Effect of Doxorubicin with Photosensitive Metal-Organic Framework Nanoparticles against Breast Cancer.
Jiang Q; Zhang M; Sun Q; Yin D; Xuan Z; Yang Y
Mol Pharm; 2021 Aug; 18(8):3026-3036. PubMed ID: 34213912
[TBL] [Abstract][Full Text] [Related]
13. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
14. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
15. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
16. Combined photothermal-chemotherapy of breast cancer by near infrared light responsive hyaluronic acid-decorated nanostructured lipid carriers.
Zheng S; Nguyen VD; Song SY; Han J; Park JO
Nanotechnology; 2017 Oct; 28(43):435102. PubMed ID: 28783035
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
20. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
